Risk factors for ventilator associated pneumonia due to carbapenemase-producing Klebsiella pneumoniae in mechanically ventilated patients with tracheal and rectal colonization

Minerva Anestesiologica

Volumn 82, Issue 6, 2016, Pages 635-640

  Sbrana, Francesco ^a   Malacarne, Paolo ^b   Bassetti, Matteo ^c   Tascini, Carlo ^b   Vegnuti, Lara ^b   Della Siega, Paola ^c   Ripoli, Andrea ^a   Ansaldi, Filippo ^d,e   Menichetti, Francesco ^b  

^a FONDAZIONE TOSCANA GABRIELE MONASTERIO   (Italy)

^b UNIVERSITY HOSPITAL OF PISA   (Italy)

^c S Maria Hospital   (Italy)

^d UNIVERSITY OF GENOA   (Italy)

^e UNIVERSITY OF GENOA   (Italy)

Author keywords

Klebsiella pneumoniae; Pneumonia; Risk factors; Ventilator associated

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CARBAPENEMASE; ERTAPENEM; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BETA LACTAMASE;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; CARBAPENEMASE PRODUCING ENTEROBACTERIACEAE; CARBAPENEMASE PRODUCING KLEBSIELLA PNEUMONIAE; CASE CONTROL STUDY; COMORBIDITY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; INTENSIVE CARE UNIT; KLEBSIELLA PNEUMONIAE; KLEBSIELLA PNEUMONIAE INFECTION; MAJOR CLINICAL STUDY; MALE; MECHANICAL VENTILATOR; MIDDLE AGED; ODDS RATIO; RECTUM; RETROSPECTIVE STUDY; RISK FACTOR; RISK REDUCTION; SEPSIS; SIMPLIFIED ACUTE PHYSIOLOGY SCORE; SOCIAL AND OCCUPATIONAL FUNCTIONING ASSESSMENT SCALE; TRACHEA; TREATMENT DURATION; VENTILATED PATIENT; VENTILATOR ASSOCIATED PNEUMONIA; BIOSYNTHESIS; ENZYMOLOGY; HETEROZYGOTE; KLEBSIELLA INFECTION; MICROBIOLOGY;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; CARRIER STATE; CASE-CONTROL STUDIES; FEMALE; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; MIDDLE AGED; PNEUMONIA, VENTILATOR-ASSOCIATED; RECTUM; RETROSPECTIVE STUDIES; RISK FACTORS; TRACHEA;

EID: 84975853389     PISSN: 03759393     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Gupta N., Limbago BM., Patel JB., Kallen AJ. Carbapen- em-resistant Enterobacteriaceae: Epidemiology and prevention. Clin Infect Dis 2011;53:60-7.
2. Centers for Disease Control and Prevention (CDC). Guidance for control of infections with carbapenein-re- sistant or carbapenemase-producing Enterobacteriaceae in acute care facilities. MMWR Morb Mortal Wkly Rep 2009:58:256-60.
3. Durante-Mangoni E., Signonello G., Andini R., Mattel A., De Cristoforo M., Murino P. et al. Colistin and rifampicin compared with colistin alone for the treatment of serious mfections due to extensively dmg-resistant Acinetobacter baumannii: A multicenter, randomized clinical trial. Clin Infect Dis 2013;57:349-58.
4. Lampati L., Maggioni E., Langer M., Malacame P., Mozzo R., Pesenti A. et al. Can routine surveillance samples from tracheal aspirate predict bacterial flora in cases of ventilator-associated pneumonia? Minerva Anestesiol 2009;75:555-62.
5. Brusselaers N., Labeau S., Vogelaers D., Blot S. Value of lower respirator- Tract surveillance cultures to predict bacterial pathogens in ventilator-associated pneumonia: systematic review and diagnostic test accuracy metaanalysis. Intensive Care Med 2013;39:365-75.
6. Tumbarello M., Trecarichi EM., Tumietto F., Del Bono V., De Rosa FG., Bassetti M. et al. Predictive Models for Identification of Hospitalized Patients Harbormg KPC- Producms Klebsiella pneumoniae. Antinncrob Agents Chemother 2014;58:3514-20.
7. Papadimitriou-Olivgeris M., Marangos M, Fhgou F., Cliristofidou M., Bartzavali C, Anastassiou ED. et al. Risk factors for KPC'-producmg Klebsiella pneumoniae enteric colonization upon ICU admission. J Antimicrob Chemother 2012;67:2976-81.
8. Papadinntriou-Olivgeris M, Marangos M, Fligou F., Christofidou M., Sklavou C, Vamvakopoulou S, et al. KPC-producing Klebsiella pneumoniae enteric colonization acquired during intensive care unit stay: The significance of risk factors for its development and its impact on mortality. Diagn Microbiol Infect Dis 2013; 77:169-73.
9. Giannella M., Trecarichi EM., De Rosa FG., Del Bono V., Bassetti M., Lewis RE. et al. Risk factors for carbapenem- resistant Klebsiella pneiunomae bloodstream mfection anions rectal carriers:A prospective observational multicentre study. Clin Microbiol Infect 2014;20:1357-62.
10. Scheduler Y., Kotlovsky T., Tarabeia J, Kaznia M., Schwartz D., Navon-Venezia S. et al. Predictors of rectal carriage of carbapenem-resistant Enterobacteriaceae (CRE) among patients with blown C'RE carriage at their next hospital encounter. Infect Control Hosp Epidemiol 2011;32:497-503.
11. Borer A., Saidel-Odes L., Eskira S, Nativ R., Riesenberg K., Livshiz-Riven I. et al. Risk factors for developing clinical mfection with carbapenem-resistant Klebsiella pneumoniae in hospital patients initially only colonized with carbapenem-resistant K pneumoniae. Am J Infect Control 2012;40:421-5.
12. Malacarne P., Boccalatte D, Acquarolo A., Agostim F., Anghileri A., Giardmo M. et al. Epidemiology of nosocomial infection in 125 Italian intensive care units. Minerva Anestesiol 2010;76:13-23.
13. Acquarolo A., Urli T., Perone G., Giannotti C, Candiani A, Latronico N. Antibiotic prophylaxis of early onset pneumonia in critically ill comatose patients. A randomized study. Intensive Care Med 2005;31:510-6.
14. American Thoracic Society;Infectious Diseases Society of America. Guidelmes for the management of adults with hospital-acquired, ventilator-associated, and healtli- care-associated pneumonia. Am J Respir Crit Care Med. 2005;171:388-416.
15. Horan TC, Andrus M., Dudeck M. CDC/NHSN surveillance definition of health care-associated mfection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008:36:309-32.
16. Prosafe; [Internet], Available from: http://prosafe.mari-onegri.it/liomepage.aspx [cited 2016. May 6].
17. Le Gall JR., Lemeshow S., Saulnier F. A new Simplified Acute Physiology- Score (SAPS Et) based on a European/North American multicenter study. JAMA 1993;270:2957-63.
18. Vincent JL., Moreno R, Takala J., Willatts S., De Mendonca A., Bruining H. et al. Tlie SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996;22:707-10.
19. Reid S, Tibshirani R. Regularization Paths for Conditional Logistic Regression: The clogitL1 Package. J Stat Sofhv 2014;58:1-23.
20. Schwaber MJ., Klarfeld-Lidji S., Navon-Venezia S., Schwartz D., Leavitt A., Carmeli Y. Predictors of carbap- enem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality. Antimicrob Agents Chemother 2008:52:1028-33.
21. Hussein K., Sprecher H., Mashiach T., Oren I, Kassis I, Finkelstein R. Carbapenem resistance among Klebsiella pneumoniae isolates: Risk factors, molecular characteristics and susceptibility patterns. Infect Control Hosp Epidemiol 2009;30:666-71.
22. Falagas ME, Rafailidis PL, Kofteridis D, Virtzili S, Chelvatzoglou FC, Papaioannou V, et al. Risk factors of carbapenem-resistant Klebsiella pneumoniae infections: A matched case control study. J Antimicrob Chemother 2007:60:1124-30.
23. Gasink LB., Edelstein PH., Lautenbach E., Synnestvedt M., Fishman NO. Risk factors and clinical impact of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae. Infect Control Hosp Epidemiol 2009;30:1180-5.
24. Correa L., Martino MD, Siqueira L, Pasternak J, Gales AC, Silva CV, et al. A hospital-based matched case-control study to identify clinical outcome and risk factors associated with carbapenem-resistant Klebsiella pneumoniae infection. BMC Infect Dis 2013; 13:80.
25. Mouloudi E, Protonotariou E., Zagorianou A., Iosifidis E., Karapanagiotou A., Giasnetsova T. et al. Bloodstream mfections caused by metallo-p-lactainase/Klebsiella pneumoniae carbapenemase-producmg K. pneumoniae among intensive care unit patients in Greece: Risk factors for infection and nnpact of type of resistance on outcomes. Infect Control Hosp Epidemiol 2010;31:1250- 6.
26. Sbrana F., Tagliaferri E., Formichi B., Pasanisi EM, Tascim C. Epidemiology' and outcome of Klebsiella pneumoniae carbapenemase-producmg Klebsiella pneumoniae in a tertiary level Cardiac Intensive Care Unit. Minerva Anestesiol 2014;80:510-1.
27. Zarkotou O., Poumaras S, Tselioti P., Dragoumanos V., Pitiriga V., Ranellou K. et al. Predictors of mortality in patients with bloodstream infections caused by KPC- producmg Klebsiella pnenmoniae and impact of appropriate antimicrobial treatment. Clin Microbiol Infect 2011;17:1798-803.
28. Petrosillo N, Giannella M, Lewis R, Male P. Treatment of carbapenem-resistant Klebsiellapneumoniae: The state of the art. Expert Rev Anti Infect Tlier 2013; 11:159-77.
29. Munoz-Price LS., Hota B, Sterner A., Weinstein RA. Prevention of bloodstream infections by use of daily chloihexidine baths for patients at a long-term acute care hospital. Infect Control Hosp Epidemiol 2009;30:1031-5.